Pharmaceutical patents in Europe

Bengt Domeij

The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a specific product for a fixed time scale. In this guide the legal patent situation is examined by a detailed analysis of case law from the European Patent Office (EPO), the international body created with the signing of the European Patent Convention (EPC). Aspects of European patent law not primarily regulated in the EPC, for example Supplementary Protection Certificates and infringement matters, are examined in the setting provided by EU law and domestic laws of European states. This book is written for the reader who understands the main characteristics of patent law and is looking for a practitioner's text on the European pharmaceutical patent law scene. Moreover, the author's remarks aim to help all readers to look at the field with fresh eyes.

「Nielsen BookData」より

[目次]

  • Acknowledgements. Foreword. Abbreviations. 1. Industrial Applicability. 2. Sufficiency of Disclosure. 3. The Claims. 4. Novelty. 5. New Medical Uses of Known Compounds. 6. Inventive step. 7. Supplementary Patent Protection. 8. Patent Infringement. 9. References. 10. Index.

「Nielsen BookData」より

この本の情報

書名 Pharmaceutical patents in Europe
著作者等 Domeijl Bengt
Domeij Bengt
シリーズ名 Stockholm studies in law
出版元 Kluwer Law International;Norstedts Juridik
刊行年月 c2000
ページ数 364 p.
大きさ 25 cm
ISBN 9139006018
9041113487
NCID BA5330969X
※クリックでCiNii Booksを表示
言語 英語
出版国 オランダ
この本を: 
このエントリーをはてなブックマークに追加

このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想